Study to Evaluate the Safety of a Gene and Cell Therapy Product in Participants With HIV That is Well-Controlled on Antiretroviral Therapy
Clinical trial NCT04561258 · COMPLETED
Trial details
- NCT number
- NCT04561258
- Sponsor
- American Gene Technologies International Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-12
- Primary completion
- 2022-08-15
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.